全文获取类型
收费全文 | 5457477篇 |
免费 | 425041篇 |
国内免费 | 16714篇 |
专业分类
耳鼻咽喉 | 78241篇 |
儿科学 | 173037篇 |
妇产科学 | 145689篇 |
基础医学 | 805817篇 |
口腔科学 | 155652篇 |
临床医学 | 504920篇 |
内科学 | 997680篇 |
皮肤病学 | 125878篇 |
神经病学 | 456592篇 |
特种医学 | 213835篇 |
外国民族医学 | 1455篇 |
外科学 | 815936篇 |
综合类 | 153438篇 |
现状与发展 | 24篇 |
一般理论 | 3043篇 |
预防医学 | 459916篇 |
眼科学 | 130912篇 |
药学 | 393161篇 |
28篇 | |
中国医学 | 14113篇 |
肿瘤学 | 269865篇 |
出版年
2021年 | 57272篇 |
2019年 | 59725篇 |
2018年 | 77453篇 |
2017年 | 59444篇 |
2016年 | 66276篇 |
2015年 | 78188篇 |
2014年 | 113035篇 |
2013年 | 178931篇 |
2012年 | 156206篇 |
2011年 | 166521篇 |
2010年 | 135296篇 |
2009年 | 134136篇 |
2008年 | 151812篇 |
2007年 | 163677篇 |
2006年 | 170224篇 |
2005年 | 164375篇 |
2004年 | 164693篇 |
2003年 | 154151篇 |
2002年 | 143641篇 |
2001年 | 219553篇 |
2000年 | 217959篇 |
1999年 | 194076篇 |
1998年 | 79256篇 |
1997年 | 73107篇 |
1996年 | 70918篇 |
1995年 | 66581篇 |
1994年 | 60585篇 |
1993年 | 55947篇 |
1992年 | 145353篇 |
1991年 | 139874篇 |
1990年 | 134577篇 |
1989年 | 130636篇 |
1988年 | 120916篇 |
1987年 | 119002篇 |
1986年 | 112573篇 |
1985年 | 109413篇 |
1984年 | 87366篇 |
1983年 | 76680篇 |
1982年 | 55192篇 |
1981年 | 50943篇 |
1980年 | 47675篇 |
1979年 | 78474篇 |
1978年 | 60140篇 |
1977年 | 52365篇 |
1976年 | 49026篇 |
1975年 | 49971篇 |
1974年 | 57577篇 |
1973年 | 55235篇 |
1972年 | 51996篇 |
1971年 | 47951篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
921.
922.
目的 探析正念减压疗法对妊娠呕吐妇女负性情绪和生活质量的影响。 方法 将2017年5月-2018年5月在我院治疗的90例妊娠呕吐妇女纳入本研究,采用数字表法随机分成研究组和对照组,每组各45例。对照组接受宣教,研究组在对照组上实施正念减压疗法。分别于入组时、干预4周和干预8周采用焦虑自评量表(self-rating anxiety scale,SAS)、抑郁自评量表(self-rating depression scale,SDS)、生活质量综合评定问卷(generic quality of life inventory-74,GQOLI-74)进行评估,比较2组妊娠呕吐妇女负性情绪和生活质量。 结果 2组SAS、SDS评分及生活质量综合评定问卷总分在组间效应、时间效应及交互效应上差异具统计学意义。 结论 妊娠呕吐妇女进行正念减压疗法,能够显著减轻妊娠呕吐妇女负性情绪和提高生活质量,值得在临床上广泛应用。 相似文献
923.
Sebastian Mondaca Walid K. Chatila David Bates Jaclyn F. Hechtman Andrea Cercek Neil H. Segal Zsofia K. Stadler Anna M. Varghese Ritika Kundra Marinela Capanu Jinru Shia Nikolaus Schultz Leonard Saltz Rona Yaeger 《Clinical colorectal cancer》2019,18(1):e39-e52
Background
Treatment of advanced anal squamous cell cancer (SCC) is usually with the combination of cisplatin and 5-fluorouracil, which is associated with heterogeneous responses across patients and significant toxicity. We examined the safety and efficacy of a modified schedule, FOLFCIS (leucovorin, fluorouracil, and cisplatin), and performed an integrated clinical and genomic analysis of anal SCC.Patients and Methods
We reviewed all patients with advanced anal SCC receiving first-line FOLFCIS chemotherapy – essentially a FOLFOX (leucovorin, fluorouracil, and oxaliplatin) schedule with cisplatin substituted for oxaliplatin – in our institution between 2007 and 2017, and performed deep sequencing to identify genomic markers of response and key genomic drivers.Results
Fifty-three patients with advanced anal SCC (48 metastatic; 5 unresectable, locally advanced) received first-line FOLFCIS during this period; all were platinum-naive. The response rate was 48% (95% confidence interval [CI], 32.6%-63%). With a median follow-up of 41.6 months, progression-free survival and overall survival were 7.1 months (95% CI, 4.4-8.6 months) and 22.1 months (95% CI, 16.9-28.1 months), respectively. Among all patients with advanced anal SCC that underwent sequencing during the study period, the most frequent genomic alterations consisted of chromosome 3q amplification (51%) and mutations in PIK3CA (29%) and KMT2D (22%). No genomic alteration correlated with response to platinum-containing treatment. Although there were few cases, patients with human papillomavirus-negative anal SCC did not appear to benefit from FOLFCIS, and all harbored distinct genomic profiles with TP53, TERT promoter, and CDKN2A mutations.Conclusions
FOLFCIS appears effective and safe as first-line chemotherapy in patients with advanced anal SCC and represents an alternative treatment option for these patients. 相似文献924.
Oga Emmanuel. A. Peters Erica. N. Mark Katrina Trocin Kathleen Coleman-Cowger Victoria. H. 《Maternal and child health journal》2019,23(2):250-257
Maternal and Child Health Journal - Background Prenatal substance use screening is recommended. The 4 P’s Plus screener includes questions on perceived problematic substance use in parents... 相似文献
925.
926.
927.
Sharisse M. Arnold Rehring Liza M. Reifler Jennifer H. Seidel Karen A. Glenn John F. Steiner 《Academic pediatrics》2019,19(5):572-580
ObjectiveClinical specialty societies recommend long-acting reversible contraceptives (LARCs) as first-line contraception for adolescent women. We evaluated whether a combined educational and process improvement intervention enhanced LARC placement in primary care within an integrated health care system.MethodsThe intervention included journal clubs, live continuing education, point-of-care guidelines, and new patient materials. We conducted a retrospective cohort study across 3 time periods: baseline (January 2013?September 2015), early implementation (October 2015–March 2016), and full implementation (April 2016–June 2017). The primary outcome was the proportion of LARCs placed by primary care clinicians among women aged 13 to 18 years compared with gynecology clinicians.ResultsKaiser Foundation Health Plan of Colorado cared for approximately 20,000 women aged 13 to 18 years in each calendar quarter between 2013 and 2017. Overall, LARC placement increased from 7.0 per 1000 members per quarter at baseline to 13.0 per 1000 during the full intervention. Primary care clinicians placed 6.2% of all LARCs in 2013, increasing to 32.1% by 2017 (P < .001), including 45.5% of contraceptive implants. Clinicians who attended educational sessions were more likely to adopt LARCs than those who did not (17.9% vs 6.4% respectively, P = .009). Neither overall LARC placement rates (relative risk, 1.9; 95% confidence interval, 0.7?5.6) nor contraceptive implant rates (relative risk, 3.0; 95% confidence interval, 0.9?9.8) increased significantly in clinicians who attended educational activities.ConclusionsThis multimodal intervention was associated with increased LARC placement for adolescent women in primary care. The combination of education and process improvement is a promising strategy to promote clinician behavior change. 相似文献
928.
929.
930.